Circulating Tumor DNA Trajectories Predict Survival in Trifluridine/Tipiracil-Treated Metastatic Colorectal Cancer Patients

Medicine, Oncology,
Circulating Tumor DNA   Metastatic Colorectal Cancer   Trifluridine/Tipiracil   Survival Rate   Molecular Biomarkers   Treatment Response   Prognosis  

ctDNA Trajectories Predict Survival in Trifluridine/Tipiracil-Treated Metastatic Colorectal Cancer Patients Academic Background Metastatic colorectal cancer (mCRC) is one of the leading causes of cancer-related deaths worldwide. Despite recent advancements in diagnosis and treatment, the prognosis for advanced-stage patients remains poor. Triflurid...